Company Filing History:
1 out of 3,923 
1 out of 13 
Years Active: 2022
Title: The Innovative Mind of Dirksen Bussiere: Pioneering Antibody Molecules
Introduction: Dirksen Bussiere, an inventive biochemist based in Emeryville, California, is recognized for his groundbreaking contributions to the field of cancer research. With a notable patent in antibody technology, Bussiere's work has the potential to revolutionize treatment options for patients diagnosed with cancer.
Latest Patents: Dirksen Bussiere holds a patent for "Antibody molecules to CD73 and uses thereof." This patent discloses antibody molecules that specifically bind to CD73, offering promising avenues for the treatment, prevention, and diagnosis of cancer.
Career Highlights: Bussiere has significantly impacted the biomedical landscape through his career at prominent companies such as Novartis AG and Surface Oncology, Inc. His tenure at these organizations has provided him with invaluable experience in pharmaceutical development and innovation.
Collaborations: Throughout his professional journey, Dirksen Bussiere has collaborated with esteemed colleagues, including Bianka Prinz and Jerry M. Thomas. These partnerships have bolstered his research endeavors and contributed to the advancement of therapeutic solutions in oncology.
Conclusion: Dirksen Bussiere's innovative spirit and commitment to cancer research highlight the critical role of inventors in advancing medical science. His patent on CD73 antibody molecules stands as a testament to the potential of targeted therapies in improving patient outcomes.